Damoiseaux, J.

disease level patient i-fabp vaccine cd patients serum damage netherland serum i-fabp levels response immunology enterocyte marsh enterocyte damage coeliac disease university villous atrophy antibody receptor control autoantibody iga-ttg coeliac vaccination system villou gluten-free diet atrophy laboratory i-fabp levels study center development aliment pharmacol autoantibody testing control group adult speci pattern recognition receptors adult cd patients iga-ttg levels testing maastricht function tissue result marsh grade quality group recognition initiative stromal course mucosal grade signi ficantly signi gluten-free standardization dutch easi team biopsy pharmacol fi eld aliment letter pathogen research serum i-fabp recovery assessment marker follow-up treatment gastroenterol pattern clinician interaction sample diagnosis